Brain Docosahexaenoic Acid Uptake and Metabolism.

Lacombe RJ Scott, Chouinard-Watkins Raphaël, Bazinet Richard P.
Molecular aspects of medicine, 2018

Abstract

Docosahexaenoic acid (DHA) is the most abundant n-3 polyunsaturated fatty acid in the brain where it serves to regulate several important processes and, in addition, serves as a precursor to bioactive mediators. Given that the capacity of the brain to synthesize DHA locally is appreciably low, the uptake of DHA from circulating lipid pools is essential to maintaining homeostatic levels. Although, several plasma pools have been proposed to supply the brain with DHA, recent evidence suggests non-esterified-DHA and lysophosphatidylcholine-DHA are the primary sources. The uptake of DHA into the brain appears to be regulated by a number of complementary pathways associated with the activation and metabolism of DHA, and may provide mechanisms for enrichment of DHA within the brain. Following entry into the brain, DHA is esterified into and recycled amongst membrane phospholipids contributing the distribution of DHA in brain phospholipids. During neurotransmission and following brain injury, DHA is released from membrane phospholipids and converted to bioactive mediators which regulate signaling pathways important to synaptogenesis, cell survival, and neuroinflammation, and may be relevant to treating neurological diseases. In the present review, we provide a comprehensive overview of brain DHA metabolism, encompassing many of the pathways and key enzymatic regulators governing brain DHA uptake and metabolism. In addition, we focus on the release of non-esterified DHA and subsequent production of bioactive mediators and the evidence of their proposed activity within the brain. We also provide a brief review of the evidence from post-mortem brain analyses investigating DHA levels in the context of neurological disease and mood disorder, highlighting the current disparities within the field.

Keywords

Brain; Docosahexaenoic acid; Fatty acid; Metabolism; Transport; Uptake.

Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

PMID:29305120
DOI:10.1016/j.mam.2017.12.004
Category:Brain / Mental Clarity

The best supplements with Docosahexaenoic Acid in Brain / Mental Clarity category:

Articles similar to "Brain Docosahexaenoic Acid Uptake and Metabolism."

  • The significance of Docosahexaenoic Acid for Brain / Mental Clarity: Docosahexaenoic Acid (DHA): An Essential Nutrient and a Nutraceutical for Brain Health and Diseases. (Docosahexaenoic acid (DHA), a polyunsaturated fatty acid (PUFA) enriched in phospholipids in the brain and retina, is known to play multi-functional roles in brain health and diseases...)
  • The role of Docosahexaenoic Acid in Brain / Mental Clarity: Health Benefits of Docosahexaenoic Acid (DHA). (Docosahexaenoic acid (DHA) is essential for the growth and functional development of the brain in infants...)
  • The impact of Docosahexaenoic Acid on Brain / Mental Clarity: A high omega-3 fatty acid multinutrient supplement benefits cognition and mobility in older women: A randomized, double-blind, placebo-controlled pilot study. ( Mobility is a key determinant of frailty in older persons, and a variety of dietary factors, such as the omega-3 fatty acid docosahexaenoic acid (DHA), are positively associated with decreased frailty and improved mobility and cognition in older persons... In this pilot study, multinutrient supplementation improved cognition and mobility in able older females at clinically relevant levels, suggesting a potential role in reducing the decline to frailty.)
  • The role of Docosahexaenoic Acid in Brain / Mental Clarity: Docosahexaenoic acid (DHA), a fundamental fatty acid for the brain: New dietary sources. (Docosahexaenoic acid (C22: 6n-3, DHA) is a long-chain polyunsaturated fatty acid of marine origin fundamental for the formation and function of the nervous system, particularly the brain and the retina of humans... In this pilot study, multinutrient supplementation improved cognition and mobility in able older females at clinically relevant levels, suggesting a potential role in reducing the decline to frailty.)
  • The impact of Docosahexaenoic Acid on Brain / Mental Clarity: Docosahexaenoic acid and cognition throughout the lifespan. (Docosahexaenoic acid (DHA) is the predominant omega-3 (n-3) polyunsaturated fatty acid (PUFA) found in the brain and can affect neurological function by modulating signal transduction pathways, neurotransmission, neurogenesis, myelination, membrane receptor function, synaptic plasticity, neuroinflammation, membrane integrity and membrane organization... In this pilot study, multinutrient supplementation improved cognition and mobility in able older females at clinically relevant levels, suggesting a potential role in reducing the decline to frailty.)
  • The significance of Docosahexaenoic Acid for Brain / Mental Clarity: Omega-3 Fatty Acids and Brain Resistance to Ageing and Stress: Body of Evidence and Possible Mechanisms. (The increasing life expectancy in the populations of rich countries raises the pressing question of how the elderly can maintain their cognitive function... In this pilot study, multinutrient supplementation improved cognition and mobility in able older females at clinically relevant levels, suggesting a potential role in reducing the decline to frailty.)
  • The role of Docosahexaenoic Acid in Brain / Mental Clarity: ω-3 Fatty Acids in the Prevention of Cognitive Decline in Humans. (The brain is a lipid-rich organ where docosahexaenoic acid (DHA) is enriched and where eicosapentaenoic acid (EPA) may have anti-inflammatory effects... In this pilot study, multinutrient supplementation improved cognition and mobility in able older females at clinically relevant levels, suggesting a potential role in reducing the decline to frailty.)

Previous article

Brain Eicosapentaenoic Acid Metabolism as a Lead for Novel Therapeutics in Major Depression.

Next article

Docosahexaenoic Acid (DHA): An Essential Nutrient and a Nutraceutical for Brain Health and Diseases.